Hypertension combined with atherosclerosis increases the risk of heart failure in patients with diabetes

Hypertens Res. 2024 Apr;47(4):921-933. doi: 10.1038/s41440-023-01529-y. Epub 2023 Dec 15.

Abstract

The increase in heart failure risk in the diabetic population when hypertension and atherosclerosis are both present is still inconclusive. The aim of this study was to explore the effects of hypertension combined with atherosclerosis in diabetic population on the risk of heart failure. We selected 10,711 patients with diabetes who participated in the Kailuan study and completed brachial-ankle pulse wave velocity (baPWV) testing for statistical analysis. The subjects were divided into the non-hypertensive non-atherosclerotic, hypertensive, atherosclerotic, and hypertensive atherosclerotic groups based on their history of hypertension and atherosclerosis. At a median follow-up of 4.15 years, 227 cases of heart failure occurred. Compared with the non-hypertensive non-atherosclerotic group, the multifactorial Cox proportional risk regression model showed that the hazard ratio (HR) for heart failure in the hypertensive atherosclerotic group was 3.08 (95% confidence interval [CI]: 1.32-7.16), whereas the HR decreased to 2.38 (95% CI: 1.01-5.63) after gradual correction of lipid-lowering, glucose-lowering, and antihypertensive drugs. The subgroup analysis and sensitivity analysis were consistent with that of total population. In conclusion, patients with diabetes exposed to both hypertension and atherosclerosis had an increased heart failure risk, which was attenuated by the use of lipid-lowering, glucose-lowering, and antihypertensive drugs.

Keywords: Atherosclerosis; Diabetes mellitus; Follow-up study; Heart failure; Hypertension.

MeSH terms

  • Ankle Brachial Index
  • Antihypertensive Agents / therapeutic use
  • Atherosclerosis* / complications
  • Diabetes Mellitus*
  • Glucose
  • Heart Failure* / drug therapy
  • Heart Failure* / etiology
  • Humans
  • Hypertension* / drug therapy
  • Lipids
  • Pulse Wave Analysis
  • Risk Factors

Substances

  • Antihypertensive Agents
  • Glucose
  • Lipids